Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab.

by Jara Baas, Lisanne Krens, Stefan Bohringer, Linda Mol, Cornelis Punt, Henk-Jan Guchelaar, Hans Gelderblom
Published 2018-01-01

Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Co...

by Jan Pander, Lieke van Huis-Tanja, Stefan Böhringer, Tahar van der Straaten, Hans Gelderblom, Cornelis Punt, Henk-Jan Guchelaar
Published 2015-01-01

Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients

by Sophie Kurk, Petra Peeters, Rebecca Stellato, B. Dorresteijn, Pim deJong, Marion Jourdan, Geert‐Jan Creemers, Frans Erdkamp, Felix deJongh, Peter Kint, Lieke Simkens, Bea Tanis, Manuel Tjin‐A‐Ton, Ankie Van Der Velden, Cornelis Punt, Miriam Koopman, Anne May
Published 2019-08-01

Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis

by Jun Yin, Shaheenah Dawood, Romain Cohen, Jeff Meyers, John Zalcberg, Takayuki Yoshino, Matthew Seymour, Tim Maughan, Leonard Saltz, Eric Van Cutsem, Alan Venook, Hans-Joachim Schmoll, Richard Goldberg, Paulo Hoff, J. Randolph Hecht, Herbert Hurwitz, Cornelis Punt, Eduard Diaz Rubio, Miriam Koopman, Chiara Cremolini, Volker Heinemann, Christophe Tournigard, Carsten Bokemeyer, Charles Fuchs, Niall Tebbutt, John Souglakos, Jean-Yves Doulliard, Fairooz Kabbinavar, Benoist Chibaudel, Aimery de Gramont, Qian Shi, Axel Grothey, Richard Adams
Published 2021-06-01